A detailed history of Center Book Partners LP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 4,184 shares of BIO stock, worth $1.49 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,184
Previous 16,086 73.99%
Holding current value
$1.49 Million
Previous $4.39 Million 68.15%
% of portfolio
0.09%
Previous 0.29%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $3.14 Million - $4.1 Million
-11,902 Reduced 73.99%
4,184 $1.4 Million
Q2 2024

Aug 12, 2024

BUY
$268.26 - $339.48 $321,643 - $407,036
1,199 Added 8.05%
16,086 $4.39 Million
Q1 2024

May 10, 2024

BUY
$304.11 - $351.99 $1.47 Million - $1.7 Million
4,833 Added 48.07%
14,887 $5.15 Million
Q4 2023

Feb 13, 2024

BUY
$269.37 - $365.04 $818,615 - $1.11 Million
3,039 Added 43.32%
10,054 $3.25 Million
Q3 2023

Nov 13, 2023

SELL
$350.25 - $422.63 $2.18 Million - $2.63 Million
-6,224 Reduced 47.01%
7,015 $2.51 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $3.73 Million - $5.05 Million
10,386 Added 364.04%
13,239 $5.02 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $1.02 Million - $1.22 Million
-2,430 Reduced 46.0%
2,853 $1.37 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $1.18 Million - $1.53 Million
3,363 Added 175.16%
5,283 $2.22 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $65,601 - $89,558
-159 Reduced 7.65%
1,920 $801,000
Q2 2022

Aug 15, 2022

BUY
$463.67 - $597.16 $963,969 - $1.24 Million
2,079 New
2,079 $1.03 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.77B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.